Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elucirem for Cardiac MR in Myocardial Scar Assessment
NCT05954559Phase 4Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadopiclenol in myocardial fibrosis, sponsored by Johns Hopkins University. Started Aug 2025; status: recruiting.
02
Drugs
gadopiclenol
03
Conditions
myocardial fibrosis
Beyond the preview
Go deeper on NCT05954559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05954559.